BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 26348234)

  • 1. Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
    Rocca MA; Preziosa P; Mesaros S; Pagani E; Dackovic J; Stosic-Opincal T; Drulovic J; Filippi M
    Radiology; 2016 Mar; 278(3):841-53. PubMed ID: 26348234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter.
    Raz E; Cercignani M; Sbardella E; Totaro P; Pozzilli C; Bozzali M; Pantano P
    Radiology; 2010 Jan; 254(1):227-34. PubMed ID: 20019140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging.
    Raz E; Cercignani M; Sbardella E; Totaro P; Pozzilli C; Bozzali M; Pantano P
    Radiology; 2010 Nov; 257(2):448-54. PubMed ID: 20858849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional but not global brain damage contributes to fatigue in multiple sclerosis.
    Rocca MA; Parisi L; Pagani E; Copetti M; Rodegher M; Colombo B; Comi G; Falini A; Filippi M
    Radiology; 2014 Nov; 273(2):511-20. PubMed ID: 24927473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
    Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
    Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural alterations of brain grey and white matter in early deaf adults.
    Hribar M; Suput D; Carvalho AA; Battelino S; Vovk A
    Hear Res; 2014 Dec; 318():1-10. PubMed ID: 25262621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
    Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter damage in Alzheimer disease and its relationship to gray matter atrophy.
    Agosta F; Pievani M; Sala S; Geroldi C; Galluzzi S; Frisoni GB; Filippi M
    Radiology; 2011 Mar; 258(3):853-63. PubMed ID: 21177393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What explains gray matter atrophy in long-standing multiple sclerosis?
    Steenwijk MD; Daams M; Pouwels PJ; Balk LJ; Tewarie PK; Killestein J; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
    Radiology; 2014 Sep; 272(3):832-42. PubMed ID: 24761837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter volume is decreased in the brain of patients with neuromyelitis optica.
    Chanson JB; Lamy J; Rousseau F; Blanc F; Collongues N; Fleury M; Armspach JP; Kremer S; de Seze J
    Eur J Neurol; 2013 Feb; 20(2):361-7. PubMed ID: 22978568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI correlates of disability progression in patients with CIS over 48 months.
    Uher T; Horakova D; Bergsland N; Tyblova M; Ramasamy DP; Seidl Z; Vaneckova M; Krasensky J; Havrdova E; Zivadinov R
    Neuroimage Clin; 2014; 6():312-9. PubMed ID: 25379444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White and gray matter damage in primary progressive MS: The chicken or the egg?
    Bodini B; Chard D; Altmann DR; Tozer D; Miller DH; Thompson AJ; Wheeler-Kingshott C; Ciccarelli O
    Neurology; 2016 Jan; 86(2):170-6. PubMed ID: 26674332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: white and gray matter damage associated with balance deficit detected at static posturography.
    Prosperini L; Sbardella E; Raz E; Cercignani M; Tona F; Bozzali M; Petsas N; Pozzilli C; Pantano P
    Radiology; 2013 Jul; 268(1):181-9. PubMed ID: 23533287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of white and grey matter in early multiple system atrophy: comparison of parkinsonian and cerebellar variants.
    Dash SK; Stezin A; Takalkar T; George L; Kamble NL; Netravathi M; Yadav R; Kumar KJ; Ingalhalikar M; Saini J; Pal PK
    Eur Radiol; 2019 Feb; 29(2):716-724. PubMed ID: 29974222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.
    Preziosa P; Pagani E; Mesaros S; Riccitelli GC; Dackovic J; Drulovic J; Filippi M; Rocca MA
    Hum Brain Mapp; 2017 Nov; 38(11):5648-5665. PubMed ID: 28792103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
    Asaf A; Evan S; Anat A
    Neuroimage Clin; 2015; 8():261-6. PubMed ID: 26106550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year regional grey and white matter volume changes with natalizumab and fingolimod.
    Preziosa P; Rocca MA; Pagani E; Storelli L; Rodegher M; Moiola L; Filippi M
    J Neurol Neurosurg Psychiatry; 2020 May; 91(5):493-502. PubMed ID: 32111638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.